Variant report

Variant	nsv898042
Chromosome Location	chr11:84877221-84965437
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr11:84511529..84512428-chr11:84891320..84891992,2	MCF-7	breast:
2	chr11:84901061..84901796-chr11:84979824..84980788,2	MCF-7	breast:
3	chr11:84965218..84967879-chr11:84970390..84972162,2	K562	blood:
4	chr11:84492333..84495051-chr11:84901283..84903076,2	MCF-7	breast:
5	chr11:84896254..84898511-chr11:84899081..84901483,2	MCF-7	breast:
6	chr11:84911038..84912682-chr11:85158292..85160996,2	MCF-7	breast:
7	chr11:84896254..84898511-chr11:84899081..84901483,2	MCF-7	breast:

Extended variants
information (count: 1429 )
Associated
traits (count: 84 )

Variant overlapped rSNPs/rCNVs (count:1429 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10898374	chr11:84877221-84877222	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs192721137	chr11:84877235-84877236	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs569114898	chr11:84877308-84877309	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs539619173	chr11:84877332-84877333	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs557797363	chr11:84877339-84877340	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs573079507	chr11:84877348-84877349	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs540124882	chr11:84877349-84877350	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs555361008	chr11:84877358-84877359	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs573251611	chr11:84877360-84877361	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs565361048	chr11:84877378-84877379	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs150832775	chr11:84877380-84877381	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs77461070	chr11:84877392-84877393	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs374218468	chr11:84877396-84877397	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs562233659	chr11:84877405-84877406	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs531055745	chr11:84877413-84877414	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs201272237	chr11:84877460-84877461	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs546355095	chr11:84877561-84877562	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs577293073	chr11:84877589-84877590	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs564661504	chr11:84877596-84877597	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs185408065	chr11:84877608-84877609	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs201499539	chr11:84877689-84877690	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs76411682	chr11:84877759-84877760	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs529296443	chr11:84877772-84877773	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs139293466	chr11:84877832-84877833	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs376476091	chr11:84877834-84877835	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs190807599	chr11:84877884-84877885	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs539291689	chr11:84877946-84877947	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs557950610	chr11:84877954-84877955	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs7110155	chr11:84877970-84877971	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs535258225	chr11:84878014-84878015	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs144995481	chr11:84878035-84878036	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs534093687	chr11:84878095-84878096	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs79055079	chr11:84878106-84878107	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs573340002	chr11:84878161-84878162	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs543801427	chr11:84878183-84878184	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs80198960	chr11:84878202-84878203	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs192154503	chr11:84878211-84878212	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs184655948	chr11:84878227-84878228	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs144312798	chr11:84878263-84878264	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs528637133	chr11:84878276-84878277	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs540963871	chr11:84878307-84878308	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs562366330	chr11:84878420-84878421	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs548078886	chr11:84878470-84878471	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs11234316	chr11:84878532-84878533	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs113634169	chr11:84878584-84878585	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs188604651	chr11:84878595-84878596	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs551535338	chr11:84878618-84878619	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs570184205	chr11:84878631-84878632	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs547656366	chr11:84878645-84878646	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs548911424	chr11:84878655-84878656	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:84)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Acute myeloid leukemia	20729466	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	16461302	CNVD
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Cervical cancer	21062161	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	17899364	CNVD
Breast cancer	17157792	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neuroblastoma	18923191	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	22429812	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Ovarian neoplasms	16753589	CNVD
Breast cancer	16608533	CNVD
Ovarian cancer	20844748	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
T-cell lymphomas	19863542	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Colorectal cancer	16912164	CNVD
Mental retardation	17847001	CNVD
Melanoma	19509136	CNVD
Sudden cardiac death	19188705	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	17053054	CNVD
Hepatocellular carcinoma	16785998	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21785460	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Cancer	20164920	CNVD
Obesity	20622171	CNVD
Breast cancer	22522925	CNVD
Developmental delay	21147756	CNVD
Bipolar disorder	19114987	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Ductal carcinoma	22052326	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Parkinson disease	21829596	CNVD

Chromatin state (count:167 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:84866000-84881200	Weak transcription	H1 Cell Line	embryonic stem cell
2	chr11:84866400-84878400	Weak transcription	H9 Cell Line	embryonic stem cell
3	chr11:84866400-84878400	Weak transcription	HUES64 Cell Line	embryonic stem cell
4	chr11:84877200-84877400	Enhancers	Placenta Amnion	Placenta Amnion
5	chr11:84877200-84878200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
6	chr11:84877400-84878400	Weak transcription	Placenta Amnion	Placenta Amnion
7	chr11:84878200-84878800	Enhancers	ES-I3 Cell Line	embryonic stem cell
8	chr11:84878200-84879000	Enhancers	HUES48 Cell Line	embryonic stem cell
9	chr11:84878200-84879000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
10	chr11:84878200-84879200	Enhancers	HUES6 Cell Line	embryonic stem cell
11	chr11:84878200-84879200	Enhancers	iPS-15b Cell Line	embryonic stem cell
12	chr11:84878200-84879200	Enhancers	iPS-18 Cell Line	embryonic stem cell
13	chr11:84878200-84879400	Enhancers	NHEK	skin
14	chr11:84878400-84878600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
15	chr11:84878400-84878600	Enhancers	HSMMtube	muscle
16	chr11:84878400-84878800	Enhancers	H9 Cell Line	embryonic stem cell
17	chr11:84878400-84878800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
18	chr11:84878400-84879000	Enhancers	HUES64 Cell Line	embryonic stem cell
19	chr11:84878400-84879000	Enhancers	Placenta Amnion	Placenta Amnion
20	chr11:84878400-84879200	Enhancers	iPS-20b Cell Line	embryonic stem cell
21	chr11:84878600-84879400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
22	chr11:84878600-84880800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
23	chr11:84878800-84880200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
24	chr11:84878800-84881200	Weak transcription	H9 Cell Line	embryonic stem cell
25	chr11:84878800-84881200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
26	chr11:84878800-84881400	Weak transcription	HSMMtube	muscle
27	chr11:84879000-84880400	Weak transcription	HUES64 Cell Line	embryonic stem cell
28	chr11:84879000-84880800	Weak transcription	HUES48 Cell Line	embryonic stem cell
29	chr11:84879000-84881200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
30	chr11:84879000-84881800	Weak transcription	Placenta Amnion	Placenta Amnion
31	chr11:84879200-84880200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
32	chr11:84879200-84880600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
33	chr11:84879200-84880800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
34	chr11:84879200-84881000	Weak transcription	HUES6 Cell Line	embryonic stem cell
35	chr11:84879400-84880600	Weak transcription	NHEK	skin
36	chr11:84880200-84880400	Enhancers	iPS-20b Cell Line	embryonic stem cell
37	chr11:84880200-84883000	Enhancers	ES-I3 Cell Line	embryonic stem cell
38	chr11:84880400-84880800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
39	chr11:84880400-84881200	Enhancers	A549	lung
40	chr11:84880400-84882200	Enhancers	HUES64 Cell Line	embryonic stem cell
41	chr11:84880600-84882200	Enhancers	NHEK	skin
42	chr11:84880600-84882400	Enhancers	iPS-15b Cell Line	embryonic stem cell
43	chr11:84880600-84883200	Enhancers	Hela-S3	cervix
44	chr11:84880800-84881800	Enhancers	NH-A	brain
45	chr11:84880800-84882000	Enhancers	HUES48 Cell Line	embryonic stem cell
46	chr11:84880800-84882600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
47	chr11:84880800-84882800	Enhancers	iPS-18 Cell Line	embryonic stem cell
48	chr11:84880800-84882800	Enhancers	iPS-20b Cell Line	embryonic stem cell
49	chr11:84880800-84882800	Enhancers	HMEC	breast
50	chr11:84880800-84883000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links